Michel BRAUN, Dominique DEWIT, Sarah DREMIER, Véronique FLAMAND, Stanislas GORIELY, Alain LEMOINE, Arnaud MARCHANT, Florence ROUFOSSE, David VERMIJLEN, Marcel TUYNDER, Stéphane TEMMERMAN, Fabienne WILLEMS

PhD in Immunology. Michel Braun is Assistant Professor at the Faculty of Medicine of the Université Libre de Bruxelles and Guest Professor at the Vrije Universiteit Brussels. He is a member of the Basic Science Committee of the European Society for Organ Transplantation and chairs the organization of the Brussels 2009 Meeting on Basic Sciences in Transplantation. He works on mouse in vivo models to analyse the effector and regulatory roles of T cells in allograft rejection. mbraun@ulb.ac.be

PhD in Immunology. The main topic of her research is the analysis of the relationship between structure and function of TLR ligands which could allow the design of further improved vaccine adjuvants. ddwit@ulb.ac.be

PhD in Biochemistry. Sarah investigates the potential of new TLR4 ligands as a novel class of pharmaceuticals for the prevention or treatment of autoimmune disorders. sdremier@ulb.ac.be

PhD in Immunology. Véronique is a Research Associate of the National Fund for Scientific Research and a lecturer at the Université Libre de Bruxelles. The objective of her research is to bring a better knowledge of the higher susceptibility of newborns to pathogens and their limited response to vaccine antigens. She supervises research studies on the shaping of neonatal innate and adaptive immunity and its involvement in the development of allergy in mouse in vivo models. vflamand@ulb.ac.be

MD, PhD, Stanislas is a Research Associate of the National Fund for Scientific Research. He studies the regulation of interleukin-12 family members during health and disease using molecular approaches and in vivo models. stgoriel@ulb.ac.be

MD, PhD, Alain is clinical nephrologist and a Research Associate of the National Fund for Scientific Research. Alain's team aims to better understand how immune responses can be pacified in the context of transplantation. This approach considers both the innate and adaptive part of immune responses and their cross-regulation by i.e. myeloid-derived suppressive cells, regulatory T cells and the role of the cholinergic anti-inflammatory pathway in transplantation. Alain gives lectures to students of the Masters of Biomedical Sciences and is an active member of the Société Francophone de Transplantation. alemoine@ulb.ac.be

MD, PhD, and Clinical Pathology specialist. Arnaud is a Senior research associate of the National Fund for Scientific Research. The objective of his research is to understand the ontogeny of the human immune system to help in the development of new vaccination strategies for your infants. Arnaud Marchant is teaching Medical Immunology to Biomedical Sciences students at the Université Libre de Bruxelles and is member of the Board of the Belgian Society of Immunology and member of the European Congenital CMV Initiative. arnaud.marchant@ulb.ac.be

MD, PhD, and Internal Medicine specialist. Florence is the Deputy Head of Clinics in the Department of Internal Medicine of the Erasmus Hospital in Brussels.  As a Clinical Research Associate of the National Fund for Scientific Research, Florence leads a research team dedicated to further understanding molecular mechanisms underlying the hypereosinophilic syndromes and identifying disease biomarkers. Currently, Florence is Director of the ULB-FOCIS Center of Excellence and Co-President of the International Eosinophil Society Symposium 2009 Meeting. froufoss@ulb.ac.be

PhD in Biomedical Sciences. During his post-doctoral stay at the National Institute of Health, Stephane built up some his expertise in the signaling pathways that initiate the immune responses. During his appointment, he identified a new genetic defect responsible for a particular primary immune deficiency in humans.  At IMI,  Stéphane investigates the role of a multi-molecular complex, called inflammasome, in innate and adaptive immune responses in early life. sttemmer@ulb.ac.be

PhD in Human Genetics (University of Paris VII). Marcel works on the monitoring of protein therapeutics and vaccine responses in whole blood assays. The objective of his work to develop easy-to-use point-of-care bio-assays for the assessment of the immune response. marcel.tuynder@ulb.ac.be

PhD in Medical Sciences. David received the Ishango-price (best young researcher of the region of Brussels) for his thesis on "Tumor cell killing by hepatic natural killer cells" and was awarded a Marie-Curie Intra-European fellowship for a post-doctoral stay at King's College London where his research was focused on human gammadelta T cells. At IMI, David studies the role of gammadelta T cells in innate and adaptive immune responses to infection in early life. dvermijl@ulb.ac.be

PhD in Immunology. Lecturer at the Université Libre de Bruxelles, Fabienne teaches general immunology to Bachelors in Biomedical Sciences and Dentistry. Fabienne investigates the cellular and molecular bases of the immaturity of the newborn immune system, focusing on cord blood dendritic cells. Her research studies aim at assessing innovative strategies to accelerate the neonatal immune reponses allowing the development of new vaccines able to prevent infectious diseases in early life. fwillems@ulb.ac.be